As the 2024 Presidential Election approaches, candidates Trump and Harris are presenting sharply contrasting visions for U.S. health care. Key issues on the agenda include drug costs, Medicare, and the implications of artificial intelligence in health policy. Both candidates aim to tackle pharmaceutical pricing, but their strategies reflect divergent approaches to reforming access and affordability. Analysts are closely watching how the election outcome could resonate throughout the health care sector, impacting everything from major pharmaceutical companies to biotech firms. Amidst varying opinions, the health care debate remains a pivotal concern for voters, marking a crucial moment for future health care policy.